Marketing off-label uses to physicians: FDA's draft (mis)guidance.
Andy
A
Gass
Jennifer
J
Wilson
D016265:Conflict of Interest; D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000592:standards / Q000639:trends; D004348:Drug Labeling / Q000331:legislation & jurisprudence / Q000592:standards / Q000639:trends; D011307:Drug Prescriptions; D017408:Guidelines as Topic; D006801:Humans; D018156:Journalism, Medical; D008389:Marketing of Health Services; D010380:Peer Review; D010820:Physicians; D011358:Product Surveillance, Postmarketing; D017594:Publication Bias; D014481:United States; D014486:United States Food and Drug Administration